The category of Type II 4-phosphatase β Inhibitors would encompass a diverse array of compounds with the capability to modulate the activity of type II phosphatases or affect related cellular signaling cascades. These inhibitors operate through a variety of mechanisms, underscoring the complexity and critical nature of phosphatase functions in cellular processes. Direct inhibitors such as Sodium orthovanadate and Calyculin A demonstrate the capacity to alter signaling pathways by affecting the phosphorylation state of proteins. This modulation is essential for the regulation of numerous cellular functions, including growth, differentiation, and apoptosis, highlighting the significance of phosphatases in maintaining cellular homeostasis.
Moreover, the inclusion of compounds like Okadaic acid and Cantharidin offers insights into the regulatory mechanisms that govern cell cycle progression and signal transduction. Their specific inhibition of protein phosphatases like PP1 and PP2A points to the potential for targeted modulation of phosphatase activity as a means to study and influence the complex networks of cellular signaling. Additionally, natural toxins such as Microcystin-LR emphasize the potent effects that phosphatase inhibition can exert on cellular physiology, affecting a broad range of biological processes from cytoskeletal organization to gene expression.
In sum, this theoretical class of Type II 4-phosphatase β Inhibitors illustrates the critical roles that phosphatases play in regulating cellular functions and the potential for chemical compounds to influence these processes through direct or indirect interactions. By targeting the activity of these enzymes, it is possible to affect a wide array of biological pathways, offering a window into the sophisticated signaling networks that underpin cellular behavior. This approach not only provides a foundation for understanding the impact of phosphatase modulation on cell physiology but also underscores the intricate balance of phosphorylation and dephosphorylation events essential for proper cellular function.
Items 1 to 10 of 11 total
画面:
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
タンパク質チロシンホスファターゼの競合的阻害剤として作用し、リン酸化状態を変化させる。 | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
プロテインホスファターゼ1および2Aを強く阻害し、関連するホスファターゼ活性に影響を及ぼす可能性がある。 | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
タンパク質リン酸化酵素PP1およびPP2Aを標的とし、同様のリン酸化酵素が関与するシグナル伝達経路を変化させる可能性がある。 | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $81.00 $260.00 | 6 | |
PP2Aを含むセリン/スレオニンホスファターゼを阻害し、関連するホスファターゼシグナル伝達に影響を及ぼす可能性がある。 | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $260.00 | 9 | |
PP2AとPP4の選択的阻害剤であり、同様のリン酸化酵素が介在するシグナル伝達経路に影響を与える可能性がある。 | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
PP1とPP2Aを阻害し、関連酵素のリン酸化ダイナミクスとシグナル伝達経路に影響を与える。 | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $48.00 $199.00 | 1 | |
PP2Aに対して作用し、同様のII型リン酸化酵素が関与する経路に影響を及ぼす可能性がある。 | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $40.00 | 4 | |
チロシンホスファターゼに結合して阻害し、関連酵素のシグナル伝達経路に影響を及ぼす可能性がある。 | ||||||
Bialaphos Sodium Salt | 71048-99-2 | sc-280620 sc-280620A | 100 mg 500 mg | $450.00 $992.00 | 1 | |
その主な作用はタンパク質合成であるが、間接的にホスファターゼ活性に影響を与える可能性もある。 | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
小胞体ストレスに関与するリン酸化酵素を間接的に標的とし、関連酵素に影響を及ぼす可能性がある。 |